Shares of Kane Biotech Inc. (CVE:KNE – Get Free Report) dropped 13.3% during mid-day trading on Friday . The company traded as low as C$0.06 and last traded at C$0.07. Approximately 537,300 shares traded hands during mid-day trading, an increase of 855% from the average daily volume of 56,261 shares. The stock had previously closed at C$0.08.
Kane Biotech Trading Down 7.7%
The company has a current ratio of 0.80, a quick ratio of 0.39 and a debt-to-equity ratio of -331.42. The company has a market cap of C$8.64 million, a PE ratio of 1.50 and a beta of 0.52. The business’s 50-day simple moving average is C$0.09 and its 200-day simple moving average is C$0.10.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Further Reading
- Five stocks we like better than Kane Biotech
- How to invest in marijuana stocks in 7 steps
- Top 4 ETFs for China Exposure After Tariff Relief
- Best Energy Stocks – Energy Stocks to Buy Now
- Build a Complete Bond Portfolio With These 4 ETFs
- Profitably Trade Stocks at 52-Week Highs
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
